CDSCO to inspect cough syrup manufacturing units

Indias drug regulator is set to inspect cough syrup manufacturing units nationwide due to child deaths linked to toxic syrups, raising serious concerns over medication safety.

• The inspections are prompted by recent child fatalities allegedly caused by contaminated cold medicine, sparking a national outcry over product safety standards in India.
• The World Health Organization has requested clarification from Indian authorities regarding regulatory shortcomings in screening for diethylene glycol and ethylene glycol in domestically marketed medications.
• Indias crackdown on syrup manufacturers marks a crucial response to increasing scrutiny over the quality of pharmaceutical products, particularly those intended for vulnerable populations like children.